
Keywords: CCN1; cysteine-rich protein 61; CX3CR1; C-X3-C motif chemokine receptor 1; CXCR2; C-X-C motif chemokine receptor type 2; GM-CSF; granulocyte-macrophage colony-stimulating factor; HAART; highly active antiretroviral therapy; HIV/AIDS; human immunodeficienc